nach oben

Current Pain and Headache Reports

Erschienen in:

01.08.2010

Musculoskeletal Pain Associated With Corticosteroid Therapy in Cancer

verfasst von: Deborah A. Frieze

Erschienen in: Current Pain and Headache Reports | Ausgabe 4/2010

Einloggen, um Zugang zu erhalten

Abstract

Corticosteroids have multiple uses in the care of the cancer patient. Although they confer benefit to the patient, high doses and extended duration of use may lead to significant adverse effects. Adverse effects such as osteoporosis-induced fractures, osteonecrosis, myopathy and myalgias can cause significant pain and have a negative impact on the patient’s quality of life. In this paper, I will review the mechanisms involved in the toxicity, risk factors, prevalence, prevention, and treatment strategies.

Fisher RI, Gaynor ER, Dahlberg S, et al.: Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin’s lymphoma. N Engl J Med 1993, 328:1002–1006.CrossRefPubMed

Cavo M, Zamagni E, Tosi P, et al.: Superiority of thalidomide and dexamethasone over vincristine-doxorubicin-dexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma. Blood 2005, 106:35–39.CrossRefPubMed

Eastell R, Reid DM, Compston J, et al.: A UK Consensus Group on management of glucocorticoid-induced osteoporosis: an update. J Intern Med 1998, 244:271–292.CrossRefPubMed

Talamo G, Angtuaco E, Walker RC, et al.: Avascular necrosis of femoral and/or humeral heads in multiple myeloma: results of a prospective study of patients treated with dexamethasone-based regimens and high-dose chemotherapy. J Clin Oncol 2005, 23:5217–5223.CrossRefPubMed

Manolagas SC, Weinstein RS: New developments in the pathogenesis and treatment of steroid-induced osteoporosis. J Bone Miner Res 1999, 14:1061–1066.CrossRefPubMed

• Fardet L, Kassar A, Cabane J, Flahault A: Corticocosteroid-induced adverse events in adults. Drug Saf 2007, 30:861–881. This is a comprehensive review of corticosteroid-induced adverse effects.CrossRefPubMed

Hollister JR: The untoward effects of steroid treatment on the musculoskeletal system and what to do about them. J Asthma 1992, 29:363–368.CrossRefPubMed

Homik J, Suarez-Almazor ME, Shea B, et al.: Calcium and vitamin D for corticosteroid-induced osteoporosis. Cochrane Database Syst Rev 2000, (2):CD000952.PubMed

Rosen LS, Gordon D, Tchekmedyian S, et al.: Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial—the Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group. J Clin Oncol 2003, 21:3150–3157.CrossRefPubMed

10.

Bower M, Stein RC, Hedley A, et al.: The use of nasal calcitonin spray in the treatment of hypercalcaemia of malignancy. Cancer Chemother Pharmacol 1991, 28:311–312.PubMed

11.

O’Brien TJ, Mack GR: Multifocal osteonecrosis after short-term high-dose corticosteroid therapy: a case report. Clin Orthop Relat Res 1992, 279:176–179.

12.

Yildiz N, Ardic F, Deniz S: Very early onset steroid-induced avascular necrosis of the hip and knee in a patient with idiopathic thrombocytopenic purpura. Intern Med 2008, 47:1989–1992.CrossRefPubMed

13.

Weldon D: The effects of corticosteroids on bone: osteonecrosis (avascular necrosis of the bone). Ann Allergy Asthma Immunol 2009, 103:91–97.CrossRefPubMed

14.

Ajmal M, Matas AJ, Kuskowski M, Cheng EY: Does statin usage reduce the risk of corticosteroid-related osteonecrosis in renal transplant population? Orthop Clin North Am 2009, 40:235–239.CrossRefPubMed

15.

Arico M, Pinta Boccalatte MR, et al.: Osteonecrosis: an emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia. Haematologica 2003, 88:747–753.PubMed

16.

Mattano LA Jr, Sather HN, Trigg ME, Nachman JB: Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children’s Cancer Study Group. J Clin Oncol 2000, 18:3262–3272.PubMed

17.

Strauss A, Su JT, Dalton VM, et al.: Bony morbidity in children treated for acute lymphoblastic leukemia. J Clin Oncol 2001, 19:3066–3072.PubMed

18.

• Campbell S, Sun CL, Kurian S, et al.: Predictors of avascular necrosis of bone in long-term survivors of hematopoietic cell transplantation. Cancer 2009, 115:4127–4135. This is a valuable study identifying potential predictors of avascular necrosis.CrossRefPubMed

19.

Shim K, MacKenzie MJ, Winquist E: Chemotherapy-associated osteonecrosis in cancer patients with solid tumours: a systematic review. Drug Saf 2008, 31:359–371.CrossRefPubMed

20.

Tombolini V, Capua A, Pompili E: Avascular necrosis of the femoral head after treatment of Hodgkin’s disease. Acta Oncol 1992, 31:64–65.CrossRefPubMed

21.

van den Berkmortel F, de Wit R, de Rooy J, DeMulder P: Osteonecrosis in patients with testicular tumours treated with chemotherapy. Neth J Med 2004, 62:23–27. [Published erratum appears in Neth J Med 2004, 62:103.]

22.

Cook AM, Dzik-Jurasz AS, Padhani AR, et al.: The prevalence of avascular necrosis in patients treated with chemotherapy for testicular tumours. Br J Cancer 2001, 85:1624–1626.CrossRefPubMed

23.

Zadegan F, Raould A, Bizot P, et al.: Osteonecrosis after allogeneic bone marrow transplantation. Clin Orthop Relat Res 2008, 466:287–293.CrossRefPubMed

24.

Cushing H: The basophil adenomas of the pituitary body and their clinical manifestations. Johns Hopkins Med J 1932, 50:137–195.

25.

Bielefeld P: Present status of cortisone myopathy [in French]. Rev Med Interne 1996, 17:255–261.CrossRefPubMed

26.

Batchelor RR, Taylor LP, Thaler HT, et al.: Steroid myopathy in cancer patients. Neurology 1997, 48:1234–1238.PubMed

27.

Walsh LJ, Wong CA, Oborne J, et al.: Adverse effects of oral corticosteroids in relation to dose in patients with lung disease. Thorax 2001, 56:279–284.CrossRefPubMed

28.

Askari A, Vignos PJ Jr, Moskowitz RW: Steroid myopathy in connective tissue disease. Am J Med 1976, 61:485–492.CrossRefPubMed

29.

•• Schakman O, Gilson H, Thissen JP: Mechanisms of glucocorticoid-induced myopathy. J Endocrinology 2008, 197:1–10. This is an excellent review with a thorough discussion of glucocorticoid-induced myopathy.CrossRef

30.

Lesser GJ, O’Rourke KS: Elevated urinary creatine excretion (% CR) is a marker of steroid-induced myopathy in patients with malignant gliomas (Meeting abstract). Proceedings of the American Society of Clinical Oncology. 1997. Abstract 1442. http://www.asco.org/ASCOv2/Meetings/Abstracts?&vmview=abst_detail_view&confID=30&abstractID=11867

31.

Lim SS: Corticosteroid induced myopathy. Available at http://emedicine.medscape.com/article/313842-overview. Accessed January 3, 2010.

32.

Blakeley JO, Peng T, Ye X, Grossman SA : Dose and duration of dexamethasone in patients with high grade gliomas (HGG): relationship to steroid myopathy (SM). American Society of Clinical Oncology Annual Meeting Proceedings Part I. J Clin Oncol 2006, 24(18S):Abstract 18517.

Titel: Musculoskeletal Pain Associated With Corticosteroid Therapy in Cancer
verfasst von: Deborah A. Frieze
Publikationsdatum: 01.08.2010
Verlag: Current Science Inc.
Erschienen in: Current Pain and Headache Reports / Ausgabe 4/2010
Print ISSN: 1531-3433
Elektronische ISSN: 1534-3081
DOI: https://doi.org/10.1007/s11916-010-0120-z

Neu im Fachgebiet AINS

Delir bei kritisch Kranken – Antipsychotika versus Placebo

16.05.2024 Delir nicht substanzbedingt Nachrichten

Um die Langzeitfolgen eines Delirs bei kritisch Kranken zu mildern, wird vielerorts auf eine Akuttherapie mit Antipsychotika gesetzt. Eine US-amerikanische Forschungsgruppe äußert jetzt erhebliche Vorbehalte gegen dieses Vorgehen. Denn es gibt neue Daten zum Langzeiteffekt von Haloperidol bzw. Ziprasidon versus Placebo.

Eingreifen von Umstehenden rettet vor Erstickungstod

15.05.2024 Fremdkörperaspiration Nachrichten

Wer sich an einem Essensrest verschluckt und um Luft ringt, benötigt vor allem rasche Hilfe. Dass Umstehende nur in jedem zweiten Erstickungsnotfall bereit waren, diese zu leisten, ist das ernüchternde Ergebnis einer Beobachtungsstudie aus Japan. Doch es gibt auch eine gute Nachricht.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2010

Headache in Multiple Sclerosis

Fasting Headache

Hypnic Headache

Migraine and Epilepsy: A Focus on Overlapping Clinical, Pathophysiological, Molecular, and Therapeutic Aspects